Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$30.71 - $45.71 $1.32 Million - $1.96 Million
-42,900 Reduced 47.93%
46,600 $1.54 Million
Q4 2021

Feb 15, 2022

BUY
$37.06 - $47.11 $196,418 - $249,683
5,300 Added 6.29%
89,500 $3.81 Million
Q3 2021

Nov 16, 2021

SELL
$40.26 - $57.37 $12.3 Million - $17.5 Million
-305,900 Reduced 78.42%
84,200 $3.73 Million
Q2 2021

Aug 16, 2021

BUY
$54.88 - $79.29 $11.9 Million - $17.2 Million
216,800 Added 125.1%
390,100 $22.2 Million
Q1 2021

May 18, 2021

BUY
$70.65 - $96.76 $6.58 Million - $9.01 Million
93,100 Added 116.08%
173,300 $13 Million
Q4 2020

Feb 17, 2021

BUY
$58.41 - $89.06 $1.83 Million - $2.79 Million
31,300 Added 64.01%
80,200 $6.94 Million
Q3 2020

Nov 17, 2020

SELL
$41.13 - $62.45 $974,781 - $1.48 Million
-23,700 Reduced 32.64%
48,900 $2.99 Million
Q2 2020

Aug 17, 2020

BUY
$25.95 - $43.15 $1.56 Million - $2.59 Million
60,100 Added 480.8%
72,600 $3.02 Million
Q1 2020

May 15, 2020

SELL
$26.15 - $77.24 $368,715 - $1.09 Million
-14,100 Reduced 53.01%
12,500 $359,000
Q4 2019

Feb 14, 2020

BUY
$60.18 - $154.77 $1.41 Million - $3.64 Million
23,500 Added 758.06%
26,600 $1.92 Million
Q2 2019

Aug 15, 2019

SELL
$157.85 - $183.09 $2.49 Million - $2.89 Million
-15,800 Reduced 83.6%
3,100 $568,000
Q1 2019

May 16, 2019

BUY
$89.33 - $163.65 $1.69 Million - $3.09 Million
18,900 New
18,900 $3.01 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.